QUEST DIAGNOSTICS INCORPORATED for QUEST DIAGNOSTICS INCORPORATED
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report | Jul 20, 2023 | $580,000 | Replaced |
| 2nd Quarter - Amendment (this page) | Oct 20, 2023 | $530,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
P.L. 117-328/H.R. 2617- Consolidated Appropriations Act of 2023, provisions related to Medicare reimbursement for clinical diagnostics laboratory services H.R. 2377/S. 1000 - Saving Access to Laboratory Services Act, provisions related to Medicare reimbursement for clinical diagnostics laboratory services Federal policy related to coverage and reimbursement of clinical laboratory services under the Medicare program
| Lobbyist | Covered position, as disclosed |
|---|---|
| EMMA LANGE | — |
| SHERRY HARPER WIDICUS | — |
Health Issues HCR
Monitor implementation of H.R. 6201, the Families First Coronavirus Response Act (Public Law 116-127), and provisions related to clinical laboratory testing for COVID-19, including coverage and reimbursement of COVID-19 tests Monitor implementation of H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act, the CARES Act, (Public Law 116-136), and provisions related to clinical laboratory testing for COVID-19, including coverage and reimbursement of COVID-19 tests, laboratory data collection and reimbursement under PAMA, and laboratory data reporting H.R.1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2) and provisions related to clinical laboratory testing for COVID-19 H.R. 2369 - the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2023 Federal policy and programs ensuring an equitable pandemic response and recovery, including coverage of COVID-19 testing services for uninsured patients Federal policy and programs regarding oncology research and development related to cancer screening, diagnosis, and survivorship H.R. 4363 - The Comprehensive Cancer Survivorship Act Federal policy related to strengthening the clinical laboratory workforce Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) H.R. 1770 - Equitable Community Access to Pharmacist Services Act H.R. 3248 - Diagnostic Lab Testing Transparency Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| EMMA LANGE | — |
| SHERRY HARPER WIDICUS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.